Erin Demien

Erin Demien has extensive work experience in corporate strategy, corporate development, and venture capital. Erin is currently serving as the Vice President of Corporate Strategy and Corporate Development at NovaSignal since October 2021. Prior to this, they worked at Intel Capital as an M&A Deal Lead from September 2018 to January 2022 and as a Senior Manager from July 2017 to September 2018.

In addition to their roles at Intel Capital, Erin was also a Board Member at the Technology Association of Oregon from June 2018 to January 2022. Before joining Intel Capital, they worked at Intel Corporation as a Venture Lead from April 2016 to July 2017 and as a Health & Life Sciences Business Innovation Manager from May 2014 to April 2016.

Erin started their career at Kaiser Associates, where they served as a Senior Manager for Kaiser's Healthcare Practice from July 2007 to March 2012. Erin also worked at Bausch + Lomb as a Manager of Corporate Development - Surgical from March 2012 to February 2013.

Overall, Erin Demien has a strong background in corporate strategy, business development, and healthcare innovation, with experience in various leadership roles in the technology and healthcare sectors.

Erin Demien received their Master of Business Administration (MBA) degree from The Wharton School, where they attended from 2016 to 2018. Prior to that, they pursued their Bachelor's degree at Dartmouth College from 2003 to 2007. Their Bachelor's degree was in a double major of Arabic and Government.